Why Now Is the Time to Buy Oracle Stock

Oracle reported a 325% year-over-year increase in Remaining Performance Obligations to $553 billion in Q3 fiscal 2026, signaling strong revenue visibility. Overall revenue rose 22% year over year, while cloud infrastructure revenue jumped 84% to nearly $5 billion. The company reaffirmed fiscal 2026 guidance and raised fiscal 2027 outlook, with revenue now expected to reach $90 billion, though the stock remains volatile after a more than 57% drop from its September 2025 high.

Analysis

Oracle’s setup is no longer a simple “AI beneficiary” story; it is a cash-flow timing trade. The market is discounting the interim capex drag, but the much larger second-order effect is that every incremental dollar of backlog converts Oracle from a cyclical software multiple into a quasi-infrastructure annuity, which should compress customer concentration and financing concerns over time if execution stays intact. That said, the path matters: if delivery slips even one or two quarters, the market will punish the stock again because the current debate is really about trust in management’s ability to monetize the pipeline, not the pipeline itself.

The key competitive implication is that Oracle’s scaling cloud buildout pressures hyperscalers on pricing in specific enterprise workloads where migration friction is high and customer switching costs are sticky. That creates a paradox: NVDA remains a supplier beneficiary near term via accelerated AI infrastructure spend, but the more Oracle succeeds in standing up capacity, the more it can redirect enterprise workloads away from more expensive incumbent clouds and force a broader margin reset across the sector. INTC is a distant second-order beneficiary only insofar as enterprise capex broadens, but it remains far less levered to the current wave than NVDA.

The contrarian read is that the stock may already be discounting the good outcome while underpricing financing and execution risk. A 57% drawdown after a peak suggests positioning has washed out, but the base case from here is likely range-bound until investors see proof of backlog conversion, not just bookings. The cleanest catalyst window is the next 2-3 earnings prints: if revenue growth holds while capex intensity plateaus, the multiple can re-rate; if not, the “cheap” valuation can get cheaper quickly.

From a factor perspective, this is a sentiment mean-reversion candidate with a fundamental catalyst, but not a low-volatility long. The move is more attractive on weakness than chasing strength, and the asymmetric risk is to the downside if guidance credibility wobbles or broader AI spending cools. The article is right that long-term visibility has improved, but the market will demand evidence of conversion efficiency before awarding durable multiple expansion.

Key Decisions for Investors

• Buy ORCL on a pullback into the next 2-4 weeks, preferably on a failed breakdown below the prior support zone, with a 6-12 month horizon; target a re-rating back toward mid-20s forward earnings if execution remains clean, but cut risk if capex intensity rises without corresponding incremental revenue.
• Structure a bullish ORCL call spread 3-6 months out rather than outright stock to isolate upside from backlog monetization while limiting downside if the market keeps punishing capex; prefer strikes just above current spot for better convexity.
• Pair trade: long ORCL / short a basket of higher-multiple cloud/software infrastructure peers that are more exposed to near-term valuation compression if enterprise AI spend broadens but remains disciplined; this isolates Oracle-specific backlog conversion versus sector multiple risk.
• Stay tactically long NVDA into any evidence of accelerating Oracle deployment spend, but trim if ORCL’s own capacity build starts to suggest vendor concentration shifts; NVDA benefits first from the capex cycle, but the trade becomes less clean if Oracle internalizes more of the stack over time.
• Avoid chasing INTC on this read-through; it is too indirect. Use any rally in INTC tied to AI infrastructure optimism as an opportunity to fade, since the earnings sensitivity to Oracle’s buildout is much lower than the market may assume.